ACCESS II Research Site — Valparaiso, Indiana

ACCESS II Research Site is a clinical research site located in Valparaiso, Indiana, United States 46383.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

ACCESS II Research Site has participated in 1 clinical trials.

Therapeutic areas: Obesity, Overweight, Chronic Weight Management.

Sponsors: Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Valparaiso

Browse all research sites in Indiana · View every site in Valparaiso

• Porter Memorial Hospital
• Porter Hospital
• Northwest Cancer Center - Valparaiso
• Research Site
• Velocity Clinical Research Valparaiso
• Northwest Indiana Center for Clinical Research
• GSK Investigational Site
• Buynak Clinical Research, P.C.
• Buynak Clinical Research
• Velocity Clin. Res Valparaiso
• Velocity Clinical Research
• American Medical Research

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for ACCESS II Research Site?

ACCESS II Research Site has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has ACCESS II Research Site conducted?

ACCESS II Research Site has 1 clinical trials on record. Their work covers Obesity, Overweight, Chronic Weight Management.

Is ACCESS II Research Site accredited by Crixeo Clinical Trials?

ACCESS II Research Site has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about ACCESS II Research Site?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.